Eledon Pharmaceuticals, Inc.
ELDN
$3.88
-$0.02-0.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.99M | 4.10M | 4.46M | 4.53M | 6.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.48M | 19.07M | 24.73M | 17.96M | 24.70M |
| Operating Income | -21.48M | -19.07M | -24.73M | -17.96M | -24.70M |
| Income Before Tax | -10.41M | -17.46M | -11.22M | -6.50M | -44.19M |
| Income Tax Expenses | 35.00K | -- | -- | -- | 431.00K |
| Earnings from Continuing Operations | -10.45M | -17.46M | -11.22M | -6.50M | -44.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.45M | -17.46M | -11.22M | -6.50M | -44.62M |
| EBIT | -21.48M | -19.07M | -24.73M | -17.96M | -24.70M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.11 | -0.23 | -0.15 | -0.08 | -0.68 |
| Normalized Basic EPS | -0.07 | -0.14 | -0.09 | -0.05 | -0.39 |
| EPS Diluted | -0.11 | -0.23 | -0.15 | -0.08 | -0.68 |
| Normalized Diluted EPS | -0.07 | -0.14 | -0.09 | -0.05 | -0.39 |
| Average Basic Shares Outstanding | 96.02M | 77.27M | 77.16M | 77.13M | 69.96M |
| Average Diluted Shares Outstanding | 96.02M | 77.27M | 77.16M | 77.13M | 69.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |